Is Provenge Angst a symbol or symptom of the times?
作者信息
Holcombe Dawn G
机构信息
DGH Consulting, South Windsor, CT, USA.
出版信息
Am J Manag Care. 2012 May;18(3 Spec No.):SP108-9.
PMID:22642274
Abstract
摘要
相似文献
1
Is Provenge Angst a symbol or symptom of the times?
Am J Manag Care. 2012 May;18(3 Spec No.):SP108-9.
2
Concerns about Provenge simmer as CMS ponders coverage.
J Natl Cancer Inst. 2011 Feb 16;103(4):288-9. doi: 10.1093/jnci/djr041. Epub 2011 Feb 8.
3
The landmark approval of Provenge, what it means to immunology and "in this issue": the complex relation between vaccines and autoimmunity.
Int Rev Immunol. 2010 Jun;29(3):235-8. doi: 10.3109/08830185.2010.490777.
4
Listening to Provenge--what a costly cancer treatment says about future Medicare policy.
N Engl J Med. 2011 May 5;364(18):1687-9. doi: 10.1056/NEJMp1103057. Epub 2011 Apr 6.
5
The Provenge decision.
Nat Clin Pract Oncol. 2007 Jul;4(7):381. doi: 10.1038/ncponc0854.
6
Citizenship in our profession.
J Urol. 2010 Oct;184(4):1248-50. doi: 10.1016/j.juro.2010.07.009. Epub 2010 Aug 17.
7
Managed care considerations. A new era of advanced prostate cancer management.
Manag Care. 2011 Sep;20(9 Suppl 5):5.
8
Dendreon vs CMS: why the Provenge coverage controversy is bigger than just one product.
Oncology (Williston Park). 2010 Sep;24(10):881-3.
9
Provenge: revolutionary technology or ethical bust?
Hum Vaccin. 2011 Apr;7(4):477-80. doi: 10.4161/hv.7.4.14189. Epub 2011 Apr 1.
10
Provenge approval means sensitive coverage decisions.
Manag Care. 2010 Sep;19(9):31-4.
Zotero 插件